{"transactions":[{"id":707440,"issuer":{"id":6943,"kind":"organization","name":"Gain Therapeutics, Inc."},"owners":[{"id":29906,"kind":"person","name":"Riley Jeffrey Scott","position":1,"cik":"0001487645","reported_name":"Riley Jeffrey Scott","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-07-17T12:31:01.000Z","date":"2026-07-15","kind":"grant","planned":false,"acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in 12 equal monthly installments commencing on July 24, 2026, subject to the Reporting Person's continuous service through the applicable vesting date."}],"balance_after":25000,"derivative":{"exercise_price":1.68,"expiration_date":"2036-07-15","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001104659-26-084434","document":"tm2620629-2_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1819411/000110465926084434/tm2620629-2_4seq1.xml","form_type":"4"}},{"id":1101987,"issuer":{"id":6943,"kind":"organization","name":"Gain Therapeutics, Inc."},"owners":[{"id":29906,"kind":"person","name":"Riley Jeffrey Scott","position":1,"cik":"0001487645","reported_name":"Riley Jeffrey Scott","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-06-25T21:30:20.000Z","date":"2025-06-24","kind":"grant","planned":false,"acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in 12 equal monthly installments commencing on July 24, 2025, subject to the Reporting Person's continuous service through the applicable vesting date."}],"balance_after":15000,"derivative":{"exercise_price":1.79,"expiration_date":"2035-06-24","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001641172-25-016540","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1819411/000164117225016540/ownership.xml","form_type":"4"}},{"id":1469115,"issuer":{"id":6943,"kind":"organization","name":"Gain Therapeutics, Inc."},"owners":[{"id":29906,"kind":"person","name":"Riley Jeffrey Scott","position":1,"cik":"0001487645","reported_name":"Riley Jeffrey Scott","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-06-27T01:30:06.000Z","date":"2024-06-24","kind":"grant","planned":false,"acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in 12 equal monthly installments commencing on July 24, 2024, subject to the Reporting Person's continuous service through the applicable vesting date."}],"balance_after":15000,"derivative":{"exercise_price":1.29,"expiration_date":"2034-06-24","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001493152-24-025337","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1819411/000149315224025337/ownership.xml","form_type":"4"}},{"id":1556958,"issuer":{"id":6943,"kind":"organization","name":"Gain Therapeutics, Inc."},"owners":[{"id":29906,"kind":"person","name":"Riley Jeffrey Scott","position":1,"cik":"0001487645","reported_name":"Riley Jeffrey Scott","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-04-01T20:01:37.000Z","date":"2024-03-28","kind":"purchase","planned":false,"acquired":true,"shares":30000,"price":3.859,"value":115770.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.7098 to $3.924, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote."}],"balance_after":30000,"source":{"system":"sec-edgar","filing":"0001493152-24-012340","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1819411/000149315224012340/ownership.xml","form_type":"4"}},{"id":1844594,"issuer":{"id":6943,"kind":"organization","name":"Gain Therapeutics, Inc."},"owners":[{"id":29906,"kind":"person","name":"Riley Jeffrey Scott","position":1,"cik":"0001487645","reported_name":"Riley Jeffrey Scott","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-06-26T20:39:25.000Z","date":"2023-06-23","kind":"grant","planned":false,"acquired":true,"shares":10500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in 12 equal monthly installments commencing on July 23, 2023, subject to the Reporting Person's continuous service through the applicable vesting date."}],"balance_after":10500,"derivative":{"exercise_price":4.5,"expiration_date":"2033-06-23","underlying":"Common Stock","underlying_shares":10500},"source":{"system":"sec-edgar","filing":"0001209191-23-039725","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1819411/000120919123039725/doc4.xml","form_type":"4"}},{"id":2152993,"issuer":{"id":6943,"kind":"organization","name":"Gain Therapeutics, Inc."},"owners":[{"id":29906,"kind":"person","name":"Riley Jeffrey Scott","position":1,"cik":"0001487645","reported_name":"Riley Jeffrey Scott","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-09-22T20:11:49.000Z","date":"2022-09-20","kind":"grant","acquired":true,"shares":10500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests fully on the day before the Issuer's next annual meeting of stockholders, subject to the Reporting Person's continued service as a director of the Issuer."}],"balance_after":10500,"derivative":{"exercise_price":3.5,"expiration_date":"2032-09-20","underlying":"Common Stock","underlying_shares":10500},"source":{"system":"sec-edgar","filing":"0001209191-22-051011","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1819411/000120919122051011/doc4.xml","form_type":"4"}},{"id":4536021,"issuer":{"id":7919,"kind":"organization","name":"Theriva Biologics, Inc."},"owners":[{"id":29906,"kind":"person","name":"Riley Jeffrey Scott","position":1,"cik":"0001487645","reported_name":"Riley Jeffrey Scott","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Options","published_at":"2016-12-02T22:06:16.000Z","date":"2016-11-30","kind":"grant","acquired":true,"shares":1129000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These options will vest monthly on a pro rata basis over 36 consecutive months."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"These options will vest monthly on a pro rata basis over 36 consecutive months."}],"balance_after":1129000,"derivative":{"exercise_price":0.8,"exercise_date":"2016-11-30","expiration_date":"2023-11-29","underlying":"Common Stock","underlying_shares":1129000},"source":{"system":"sec-edgar","filing":"0001144204-16-137742","document":"v454263_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/894158/000114420416137742/v454263_4.xml","form_type":"4"}}]}